Healthcare · Vaccine antigens production

Vaccine antigens production in Mauritania in 2026

Mauritania does not produce vaccine antigens — in 2026, the figure was 0 million doses. The country is entirely dependent on international immunization programs such as GAVI and purchases vaccines abroad. The lack of domestic biopharmaceutical production is due to insufficient investment, technology, and expertise. Instead, Mauritania focuses on livestock and fisheries — the key sectors of its economy. In vaccine production, the country ranks 72nd out of 197 countries.

Data for 2026 · unit: million doses
Position

Mauritania world ranking

#72 / 197

Country position on the scale from last to first place for this indicator.

MR
#72
#197#1
Trend

Change over time

Change in indicator over the available period.

0
1950
0
1990
0
2000
0
2010
0
2020
0
2025
0
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Mauritania — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Mauritania's rank by Vaccine antigens production?
Mauritania ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Mauritania?
Over the available period the indicator changed from 0 to 0 million doses.